Vera Therapeutics, Inc. (VERA)
$33.72+4.49%Close
SELLRECOVERY · day 4
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $2.4B
- Avg volume
- 1.7M
- Beta
- 0.95
- P/E (TTM)
- -5.75
- Short % float
- 26.12%
- Days to cover
- 9.4
- SI change
- +1.3%
- 1W
- +6.61%
- 1M
- -4.88%
- 3M
- -0.94%
- YTD
- -30.65%
- vs SPY 1W
- +7.80%
- vs SPY 1M
- -8.20%
- vs SPY 3M
- -3.33%
- vs SPY YTD
- -42.40%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- KYTXBUYKyverna Therapeutics, Inc.RECOVERYQ -16$8.24-2.14%
- SIONSELLSionna Therapeutics, Inc.CRISISQ -31$5.59+5.67%
- ACETBUYAdicet Bio, Inc.RECOVERYQ -27$8.90-3.16%
- CGEMBUYCullinan Therapeutics, Inc.BULLQ 6$21.82+0.65%
- CMPXBUYCompass Therapeutics, Inc.RECOVERYQ -12$2.40+0.00%
- ENTXBUYEntera Bio Ltd.RECOVERYQ 10$3.42+5.88%
- IMNMBUYImmunome, Inc.BULLQ 22$28.01-1.79%
- PVLASELLPalvella Therapeutics, Inc.BEARQ 14$145.75+2.61%
- SLSBUYSELLAS Life Sciences Group, Inc.RECOVERYQ -8$14.33-7.31%
- UNCYBUYUnicycive Therapeutics, Inc.RECOVERYQ -4$5.34-5.15%
- XENESELLXenon Pharmaceuticals Inc.BEARQ 26$60.56-0.35%
- CNTXBUYContext Therapeutics Inc.CRISISQ -15$0.47-6.00%
Industry peers
FMP comparable companies · ranked by market cap
- ABCLBUYAbCellera Biologics Inc.$3.5BRECOVERYQ -7$11.57-6.27%
- QUREBUYuniQure N.V.$3.4BRECOVERYQ 20$48.89-1.88%
- VRDNBUYViridian Therapeutics, Inc.$2.8BRECOVERYQ -2$24.50-1.11%
- IMNMBUYImmunome, Inc.$2.7BBULLQ 22$28.08-1.79%
- CLDXBUYCelldex Therapeutics, Inc.$2.7BBULLQ 5$39.94+0.47%
- PHVSBUYPharvaris N.V.$2.5BBULLQ 17$36.39+2.87%
- NUVBBUYNuvation Bio Inc.$2.4BRECOVERYQ 7$6.83-2.45%
- HRMYBUYHarmony Biosciences Holdings, Inc.$2.2BBULLQ 0$38.07+0.92%
- BHVNSELLBiohaven Ltd.$2.0BCRISISQ 19$13.50-1.23%
- JANXBUYJanux Therapeutics, Inc.$1.1BRECOVERYQ 12$17.28+6.96%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 19
- VALUE
- 8
- GROWTH
- 45
- GARP
- 6
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-50.5%
REV YoY-
ROE-84.1%
EPS YoY-
ROA-75.4%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-5.75
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B5.94
P/FCF-
EV/EBITDA-6.27
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E18.45
ALTMAN Z-
CURR RATIO10.92
ND/EBITDA-
BETA0.95
